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Summary
Bullous congenital ichthyosiform erythroderma (BCIE)
is characterized by blistering and erythroderma in in-
fancy and by erythroderma and ichthyosis thereafter.
Epidermolytic hyperkeratosis is a hallmark feature of
light and electron microscopy. Here we report on four
individuals from two families with a unique clinical dis-
order with histological findings of epidermolytic hyper-
keratosis. Manifesting erythema and superficial erosions
at birth, which improved during the first few months of
life, affected individuals later developed palmoplantar
hyperkeratosis with patchy erythema and scale else-
where on the body. Three affected individuals exhibit
dramatic episodic flares of annular, polycyclic erythem-
atous plaques with scale, which coalesce to involve most
of the body surface. The flares last weeks to months. In
the interim periods the skin may be normal, except for
palmoplantar hyperkeratosis. Abnormal keratin-fila-
ment aggregates were observed in suprabasal keratino-
cytes from both probands, suggesting that the causative
mutation might reside in keratin K1 or keratin K10. In
one proband, sequencing of K1 revealed a heterozygous
mutation, 1436TrC, predicting a change of isoleucine
to threonine in the highly conserved helix-termination
motif. In the second family, a heterozygous mutation,
1435ArT, was found in K1, predicting an isoleucine-
to-phenylalanine substitution in the same codon. Both
mutations were excluded in both a control population
and all unaffected family members tested. These findings
reveal that a clinical phenotype distinct from classic
BCIE but with similar histology can result from K1 mu-
tations and that mutations at this codon give rise to a
clinically unique condition.
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Introduction
Keratins are polymeric proteins that form the interme-
diate-filament cytoskeleton of epithelial keratinocytes.
Mutations in keratins have been identified in a variety
of inherited disorders of skin and other epithelia, all of
which share in common fragility of the skin and hyper-
keratosis. These disorders vary in severity and in the
relative proportion of blistering to scaling. Mutations in
K5 and K14, the basal keratins, result in the epider-
molysis bullosa simplex disorders (Bonifas et al. 1991;
Coulombe et al. 1991; Lane et al. 1992). Mutations in
suprabasal keratins K1 and K10 are causal in bullous
congenital ichthyosiform erythroderma (BCIE), also
known as “epidermolytic hyperkeratosis” (Cheng et al.
1992; Chipev et al. 1992; Rothnagel et al. 1992). Mu-
tations in K2e, a protein expressed in the upper layers
of the epidermis, are responsible for ichthyosis bullosa
of Siemens, a condition marked by superficial peeling or
molting of the skin (McLean et al. 1994b; Rothnagel et
al. 1994). Mutations in K9 have been found in pal-
moplantar hyperkeratosis with epidermolytic hyperker-
atosis (Bonifas et al. 1994).
In its classic form, BCIE is characterized by blistering,
erythroderma, and hyperkeratosis evident at birth.
Gradually, blistering improves and erythroderma less-
ens, but the hyperkeratosis persists and may worsen.
Usually the condition is generalized and relatively stable
in its expression in a given individual. Suprabasal clumps
of keratin filaments and cytolysis are seen on light mi-
croscopy and are confirmed by electron microscopy.
These features give the condition one of its names, “ep-
idermolytic hyperkeratosis,” although this histological
finding is not limited to this disorder. We present two
families with a distinctive phenotype of cyclic ichthyosis
(Francis et al. 1996), with histological evidence of epi-
dermolytic hyperkeratosis, in whom we have identified
mutations in the same codon of K1.
Subjects, Material, and Methods
Clinical Summaries
TH, the only person in his family to be affected, pre-
sented with blisters and erosions at age 12 h. A provi-
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Figure 1 a and b, Patient TH at age 10 d. Scattered blisters,
erosions, and peeling, along with patchy erythema, are evident.
Figure 2 a, Patient TH at age 22 mo. The skin is almost entirely
clear. The hemangioma on the neck is an unrelated finding. b,Explosive
gyrate erythema and peeling in patient TH at age 30 mo. c and d,
Patient TH at age 2 years 9 mo. Patchy circinate lesions reminiscent
of EKV are present.
sional diagnosis of and treatment for staphylococcal
scalded skin was given. Blisters recurred at day 10; a
diagnosis of epidermolysis bullosa simplex was enter-
tained (fig. 1). At age 1 mo, the individual developed
thickening of the palms and soles and patchy erythema.
By the age of 2 years, he had experienced occasional
blistering of the skin, hyperkeratosis of the palms and
soles, and explosive bouts of generalized erythroderma
(fig. 2). By age 3 years, plaques of thickened, sharply
demarcated erythema and hyperkeratosis had appeared
on his chest, groin, back, axillae, and flexures. Now
almost 5 years of age, he has experienced one additional
episode of explosive erythroderma necessitating
hospitalization.
The phenotype of patient TH was recognized to be
identical to that of a second proband, BM (fig. 3), who
had been examined 10 years earlier. The second proband
had migratory, erythematous, thickened plaques over his
body and palmar and plantar hyperkeratosis. The fea-
tures of the condition varied greatly among his affected
relatives. His mother had involvement of her palms and
soles and very subtle changes in her axillae at the time
of our initial evaluation of patient BM. She reported
intermittent involvement of the volar aspects of her fore-
arms. His aunt, patient JS, was most severely involved,
with episodic dramatic bouts of widespread erythema,
vesicles, and pustules and had been given a misdiagnosis
of pityriasis rubra pilaris and pustular psoriasis prior to
biopsy confirmation of BCIE. Between the bouts of
erythrodermic flare, she had palmar and plantar hyper-
keratosis and plaques of mild erythema and scale in her
folds (fig. 4). Her two affected children had only palm
and sole involvement. Other family members identified
by the index case’s mother as being affected had in-
volvement limited to the scalp, the palms and soles, or
the abdomen (fig. 5).
Light and Electron Microscopy
Skin biopsies were obtained, with appropriate con-
sent, from three affected individuals and from unaffected
control subjects. Tissue was fixed in 10% neutral buf-
fered formalin, processed into paraffin for routine his-
tological analysis, and stained with hematoxylin and eo-
sin. Samples were fixed in sodium cacodylate buffer
containing 2.5% glutaraldehyde and 2% paraformal-
dehyde, postfixed in osmium tetroxide, en bloc stained
in aqueous uranyl acetate, dehydrated through a graded
series of ethanol and propylene oxide, and embedded in
epoxy resin. One-micron-thick sections were stained
with Richardson’s blue, for light microscopy. Ultrathin
sections were sequentially stained with uranyl acetate
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Figure 3 a, Patient BM at age 3 years, with sharply demarcated
plaques. b and c, Patient BM at age 18 years. There has been migration
of areas of involvement.
Figure 4 Patient JS, the aunt of patient BM. a, Minimal in-
volvement of popliteal fossa, with mild lichenification and scaling. b,
Hyperkeratosis of soles.
and lead citrate and were viewed by means of a Philips
420 transmission-electron microscope.
Immunofluorescence and Immunoperoxidase
Microscopy
Unfixed skin-biopsy samples were submerged in OCT
(optimal cutting temperature) and quick frozen in a slush
of alcohol and dry ice. Sections 6 mm thick were mounted
on glass slides and were immunolabeled according to
standard protocols. Epidermal staining using mono-
clonal antibodies AE1, AE3, and AKH2 and the poly-
clonal antibody to keratin K2e was performed according
to methods described elsewhere (Holbrook et al. 1987;
McLean et al. 1994b).
Mutational Analysis
DNA was extracted, by standard methods, from pe-
ripheral blood lymphocytes from both probands, the af-
fected aunt and mother of patient BM, the unaffected
parents and brother of patient TH, and 50 normal, un-
related white individuals. cDNA was prepared from cry-
osections of snap-frozen skin-biopsy material obtained
from patient TH, as described elsewhere (McLean et al.
1995). Near-full-length K1 cDNA was amplified by
primers K1p1 (5′-TTC CGG GTC TGG GTA CCG
AAG-3′) and K1p6 (5′-CTT ACT CAC ACT CAC GTT
CGG GGC-3′), under the following PCR conditions: 1
cycle at 94C for 5 min; 35 cycles at 94C for 45 s, 56C
for 1 min, and 72C for 2 min; and, last, 1 cycle at 72C
for 10 min. PCR buffer containing 1 mM of MgCl2,
10% (v/v) dimethylsulfoxide, and 1 U of AmpliTaq poly-
merase (Perkin-Elmer) was used in a 50-ml reaction vol-
ume. The mutation 1436TrC creates a new BsmAI site.
For genomic confirmation, forward primer K1p5 (5′-
TCC ATC AGT GAT GCA GAG CAG CGA-3′) was
used in combination with K1p6 (above). PCR products
(20 ml) were digested overnight with 4 U of BsmAI in a
total volume of 30 ml and were analyzed on 2.5 NuSieve
agarose minigels.
The mutation in patient BM was identified in a PCR
product amplified from genomic DNA by means of the
HK1 primers and reaction conditions described else-
where (Rothnagel et al. 1992). The PCR product was
sequenced directly (Kogan and Gitschier 1989) by means
of the forward HK1 primer. Ninety-two normal keratin
1 alleles were tested for the 1435ArT mutation, by al-
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Figure 5 Pedigree of patient BM
lele-specific hybridization of PCR products, amplified
from genomic DNA of 46 unaffected, unrelated indi-
viduals, with primers HK1. Samples were hybridized as
described elsewhere (Stephens et al. 1997), with the oli-
gonucleotides 5′-TGG ATC TGG AG[A/T] TTG CCA
CCT A-3′, where the square brackets enclose the wild-
type and mutant base that varied between the two allele-
specific oligonucleotides. Blots were washed at 70C.
Results
Keratin-Filament Abnormalities Revealed by
Histological and Ultrastructural Analysis
Light microscopy (fig. 6A) of a skin-biopsy sample
from patient TH showed an intraepidermal vesicle, ep-
idermal spongiosis, eosinophils and neutrophils in the
epidermis, and a superficial and deep perivascular infil-
trate in the dermis. Immunofluorescence staining for IgA,
IgE, IgG, IgM, C3, C1q, C4, and fibrinogen was neg-
ative. On electron microscopy (fig. 6C), cytolysis and
circumscribed clumps of keratin filaments, some asso-
ciated with desmosomes, and dense whorls of keratin
filaments were seen in the lower and middle spinous
layers. There appeared to be some dissolution of basal
cells and some dyskeratosis. Results of immunohisto-
chemical staining with keratin antibodies AE1, AE3, and
AKH2 appeared to be essentially normal, although AE1
staining was noted in the spinous and cornified layers,
and positive staining with polyclonal antibody to K2e
was seen in the lower and upper spinous cells (not
shown). Examination of skin-biopsy material derived
from patient BM (data not shown) and his aunt, patient
JS, revealed cytolysis and dense aggregates, on light mi-
croscopy (fig. 6B). Keratin-filament aggregation in su-
prabasal keratinocytes was confirmed by electron mi-
croscopy, consistent with the presence of BCIE (fig. 6D).
Although the clinical phenotype in both these families
was observed to be markedly different from that typi-
cally seen in patients with BCIE, the presence of overt
keratin-filament abnormalities in the suprabasal kera-
tinocytes of affected members in both kindreds led us
to postulate that mutations in either K1 or K10 might
underlie this disorder. Since palmoplantar keratoderma
was seen in both families, and since this aspect of the
BCIE phenotype has been reported to be more severe in
individuals carrying K1 mutations (DiGiovanna and
Bale 1994), this gene was selected for initial analysis, in
preference to K10.
Mutations in Codon 479 of K1 in Two Kindreds with
Cyclic Ichthyosis
Direct sequencing of the PCR-amplified K1 rod do-
main of patient TH revealed a heterozygous transition
mutation, 1436TrC, in the K1 gene, predicting the
amino acid change of isoleucine to threonine in codon
479, I479T (fig. 7b). This alteration is in the highly con-
served portion of helix 2B of K1, known as the “helix-
termination motif.” The mutation creates a new rec-
ognition site for the restriction enzyme BsmAI, which
was used to confirm the mutation in the proband and
to exclude it from 50 normal unrelated individuals, by
BsmAI digestion of K1 genomic PCR fragments. Neither
TH’s parents nor his healthy sibling carried the
mutation.
Direct sequence analysis of the PCR-amplified car-
boxy terminus of the K1 rod domain of patient BM
revealed a heterozygous mutation, 1435ArT (fig. 7c),
that predicts a substitution of the isoleucine at codon
479 by a phenylalanine residue, I479F. As expected, the
mutation was carried by the patient’s affected mother
and affected maternal aunt but was not found in a screen
of 96 K1 alleles of unaffected unrelated individuals (data
not shown).
Discussion
The keratins are the major structural molecules of the
epidermis and constitute a group of 130 distinct inter-
mediate-filament proteins (Corden and McLean 1996,
and references therein). They are divided into two
groups, type I acidic keratins (K9–K20), whose genes
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Figure 6 A–D, Light microscopy revealing intact basal cells and
cytolysis of suprabasal keratinocytes in patient TH (A and C) and
patient VS (B and D). Densely stained material is observed in the
spinous layer (arrows). Electron microscopy of skin from patient TH
(C) and patient VS (D) shows that basal keratinocytes (b) have evenly
distributed keratin filaments, whereas in suprabasal cells there is ab-
normally dense keratin-filament aggregation including circumscribed
clumps of keratin filaments (arrows).
reside at chromosome 17q12–q21, and type II basic ker-
atins (K1–K8), localized to 12q11–q13. The acidic and
basic proteins form dimers, which undergo higher-order
polymerization to form 10-nm intermediate filaments
that extend throughout and confer mechanical strength
to epidermal keratinocytes. The expression of keratin
protein pairs is specific for site and differentiation state.
For example, K5 and K14 are the keratins of the basal
epidermal keratinocytes; K1 and K10 are present in the
suprabasal cells; and K2e is normally expressed in the
upper spinous cells.
Keratins share the domain organization of all inter-
mediate-filament proteins—a central coiled-coil rod do-
main containing four alpha-helical segments (1A, 1B,
2A, and 2B) separated by three nonhelical linker ele-
ments (L1, L12, and L2) (Quinlan et al. 1994). The rod
domain is flanked by nonhelical head and tail domains.
In the regions where the rod domain starts and finishes
are two short, highly conserved sequences termed the
“helix boundary motifs.” The isoleucine residue that
was found to carry the causative mutation in both fam-
ilies is fully conserved, not only in all type I and type II
keratins but in all intermediate-filament proteins of all
species cloned to date (Quinlan et al. 1994). Substitution
within this protein motif, which has been implicated in
molecular-overlap interactions (Steinert et al. 1993), is
predicted to have a detrimental effect on keratin-filament
assembly and/or the integrity in keratinocytes where K1
is expressed, consistent with the histological and ultra-
structural findings in suprabasal keratinocytes. Muta-
tions in nearby residues have been reported in several
other keratin disorders in which filament aggregation is
seen on electron microscopy (Corden and McLean 1996,
and references therein; Irvine et al. 1997).
Mutations in the boundary-motif sequences of K1 and
K10 have been reported in several families with the clas-
sic BCIE phenotype of severe, generalized epidermolytic
hyperkeratosis (reviewed by Corden and McLean 1996).
An unusual mutation in the VI variable domain of K1
has also been implicated in a family with nonepider-
molytic palmoplantar hyperkeratosis (Kimonis et al.
1994). In individuals with BCIE, mutations in K1 have
been reported to be more likely to result in palmar and
plantar involvement than do mutations in K10 (Di-
Giovanna and Bale 1994). Palmoplantar keratoderma
was observed in both families in the present study, a
finding consistent with this reported correlation. Fur-
thermore, a mutation in the 2B helical segment (R83E)
of K10, the partner keratin of K1, resulting in a similar
phenotype with blistering in childhood, accompanied
with and followed by polycyclic erythematous hyper-
keratosis but without palmoplantar involvement, has
been reported (Joh et al. 1997).
The clinical picture in these two families and in the
family studied by Joh et al. (1997) is quite distinct from
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Figure 7 A–C, Direct sequencing of K1 genomic PCR fragments. A, Normal K1 sequence from the region of exon 7 encoding the helix-
termination motif. The reverse strand is shown, complementary to bases 1443–1429 of the K1 cDNA (base 1 is assumed to be the A of the
initiating methionine codon [Johnson et al. 1985]). B, K1 sequence equivalent to that shown in panel A, derived from patient TH. The arrow
indicates the heterozygous mutation 1436TrC (the reverse strand ArG is shown). This mutation predicts the amino acid substitution 1479T.
C, Sequence of the forward strand of K1, detailing bases 1432–1440, derived from patient BM, showing the heterozygous 1435ArT mutation,
which predicts the amino acid substitution 1479F.
previous reports of BCIE. These distinctive features in-
clude recurrent explosive erythroderma, similar to eryth-
rodermic psoriasis, and migratory erythematous scaling
plaques, similar to erythrokeratodermia variabilis (EKV
[MIM 133200]), along with palmar and plantar hyper-
keratosis and mild ichthyotic changes in flexures and
scalp. Nonetheless, the ultrastructural findings in skin
are identical to those in BCIE.
The cyclic nature of the disorder and the marked var-
iability in expression within patient BM’s family are not
readily explained. The positive staining for K2e in the
lower spinous cells, where it is usually not present (Col-
lin et al. 1992), suggests the possibility that its premature
expression might provide substitute functional keratin
molecules that can aggregate normally and mitigate dis-
ease expression. Our proposal of a distinct cyclic ich-
thyosis phenotype associated with alterations in this spe-
cific codon is supported by the recent report (Michael
et al. 1997) that a family with episodic psoriasiform
plaques on the body, with chronic and severe palmo-
plantar keratoderma, had the same mutation as we
found in patient BM.
The cyclic ichthyosis disorder described here might be
confused with EKV, a distinct autosomal dominant skin
disorder, also characterized by migratory geographic
plaques of erythema. The major ultrastructural feature
of EKV is a reduction in the number of keratinosomes
in the granular layer. Clumping of tonofilaments is an
inconstant finding. The EKV phenotype has been linked
to a locus on chromosome 1p (van der Schroeff et al.
1988), and mutations in connexin 31 (GJB3) have been
implicated (Richard et al. 1998). The possibility of mu-
tations in either K1 or K10 should be considered in
families that present with EKV but do not show linkage
to the 1p locus where connexin 31 resides.
In summary, we have described a distinct autosomal
dominant disorder of keratinization characterized by
marked variability in severity among affected relatives
and, over time, in an individual. It is easily recognizable
and is differentiated from other keratinizing disorders
by bouts of polycyclic, geographic plaques of sharply
demarcated erythema and hyperkeratosis, along with
palmar and plantar hyperkeratosis. Different base
changes in the same codon of K1 are responsible for the
disorder in the two unrelated families reported here and
in a third family recently presented in an abstract (Mi-
chael et al. 1997).
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